US 10000522
Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infections
granted A61PA61P31/14
Quick answer
US patent 10000522 (Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infections) held by Ligand Pharmaceuticals Incorporated expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P31/14